Dose-Finding Phase I and Pharmacokinetic Study of Capecitabine (Xeloda) in Combination with Epirubicin and Cyclophosphamide (CEX) in Patients with Inoperable or Metastatic Breast Cancer

Publisher： Karger

E-ISSN： 1423-0232|72|5-6|330-337

ISSN： 0030-2414

Source： Oncology, Vol.72, Iss.5-6, 2008-01, pp. : 330-337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paclitaxel, Epirubicin and Cyclophosphamide Combination in First-Line Treatment of Metastatic Breast Cancer: A Dose Escalation Study

By  

Oncology, Vol. 66, Iss. 3, 2004-06 ,pp. : 185-191

Karger

Access to resources Recommend Favorite

A Phase II Study of Epirubicin, Cisplatin and Capecitabine Combination Chemotherapy in Patients with Metastatic or Advanced Gastric Cancer

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 333-340

Karger

Access to resources Recommend Favorite

Capecitabine with Weekly Paclitaxel for Advanced Breast Cancer: A Phase I Dose-Finding Trial

By  

Oncology, Vol. 67, Iss. 2, 2004-10 ,pp. : 117-122

Karger

Access to resources Recommend Favorite

Intensified Adjuvant Cyclophosphamide, Methotrexate and 5-Fluorouracil Therapy: A Dose-Finding Study for Ambulatory Patients with Breast Cancer

By  

Oncology, Vol. 56, Iss. 2, 1999-02 ,pp. : 103-109

Karger

Access to resources Recommend Favorite

Quality of Life under Capecitabine (Xeloda®) in Patients with Metastatic Breast Cancer: Data from a German Non-Interventional Surveillance Study

By  

Oncology Research and Treatment, Vol. 37, Iss. 12, 2014-11 ,pp. : 748-755

Karger

Access to resources Recommend Favorite